Clinical trial
Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients (MEAS Study)
NCT04645420 is registered in ClinicalTrials.gov with Cliniques universitaires Saint-Luc- Université Catholique de Louvain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients (MEAS Study)
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 12, 2020
- Completion date
- February 10, 2023
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psoriatic arthritis